source
- Stakeholders urge FDA to create drug-repurposing framework that avoids disincentives and stays within authorityStakeholders, including patients and healthcare industry groups, told the FDA that repurposing existing drugs offers significant opportunities for new treatments. They warned that any new repurpos…
- EMA issues guidance to curb microbial contamination in non-sterile medicines; MHRA reports record drug approvalsThe European Medicines Agency has issued new guidance that outlines technical and organisational measures to reduce the risk of microbial contamination in non-sterile pharmaceutical products. The…